tradingkey.logo
tradingkey.logo
검색

Elanco Animal Health Inc

ELAN
관심 목록에 추가
24.086USD
+0.126+0.53%
시장 운영 시간 ET시세는 15분 지연됩니다
11.97B시가총액
손실P/E TTM

Elanco Animal Health Inc

24.086
+0.126+0.53%

자세한 내용은 Elanco Animal Health Inc 회사

Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.

Elanco Animal Health Inc 정보

종목 코드 ELAN
회사 이름Elanco Animal Health Inc
상장일Sep 20, 2018
CEOSimmons (Jeffrey N)
직원 수9000
유형Ordinary Share
회계 연도 종료Sep 20
주소450 Elanco Circle
도시INDIANAPOLIS
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호46221
전화18773526261
웹사이트https://www.elanco.com/
종목 코드 ELAN
상장일Sep 20, 2018
CEOSimmons (Jeffrey N)

Elanco Animal Health Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
187.21K
+9.01%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
126.45K
+13.34%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
108.15K
+15.60%
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
101.69K
+16.59%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
94.39K
+4.96%
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
83.83K
+35.69%
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
71.18K
+12.12%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
187.21K
+9.01%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
126.45K
+13.34%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
108.15K
+15.60%

자주 묻는 질문

Elanco Animal Health Inc의 상위 5대 주주는 누구인가요?

Elanco Animal Health Inc의 상위 5대 주주는 다음과 같습니다: Mr. Jeffrey N. (Jeff) Simmons

Elanco Animal Health Inc(ELAN)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Elanco Animal Health Inc의 주식을 보유한 기관은 총 950곳이며, 이들이 보유한 주식의 총 가치는 약 549.30M로 전체 발행 주식의 109.98%를 차지합니다. 이는 2025Q4 대비 -60070109.00 증가한 수치입니다.

Elanco Animal Health Inc의 최대 수익원은 무엇인가요?

2026Q1 기준, Elanco Animal Health Inc의 Farm Animal 부문이 가장 높은 매출을 기록했으며, 금액은 2.36B로 전체 매출의 50.10%를 차지했습니다.
KeyAI